Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 237,827,090 papers from all fields of science
Search
Sign In
Create Free Account
BRCAPRO
A computer program that uses statistics to predict whether a person has an inherited mutation (change) in the BRCA1 and BRCA2 genes. People who have…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Genetic risk algorithm:Type:Pt:^Patient:Nom
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Abstract CT337: Phase I/Ib study of the PARP inhibitor (PARPi) olaparib (O) with carboplatin (C) in triple negative breast cancer (TNBC) at low genetic risk (NCT00647062)
Victoria L. Chiou
,
E. Kohn
,
+8 authors
Jung-Min Lee
2014
Corpus ID: 72015072
Background: PARPi O demonstrates single agent activity in breast and ovarian cancer (Br/OvCa) pts with germline BRCA1/2 mutation…
Expand
Review
2013
Review
2013
Abstract P2-12-04: Evaluation of BRCA 1/2 mutation-carrier probability models, BRCAPRO and myriad II, in the Japanese population
M. Ito
,
Y. Yasuda
,
A. Furuta
,
N. Ohuchi
2013
Corpus ID: 72153355
Background: It is important to select high-risk group with a BRCA1/2 mutation and recommend them to provide genetic counseling…
Expand
Review
2012
Review
2012
Aromatase inhibition to decrease background parenchymal enhancement: premedication before magnetic resonance imaging?
Julliette M. Buckley
,
K. Hughes
Menopause
2012
Corpus ID: 205613538
M agnetic resonance imaging (MRI) of the breast is a useful tool in diagnosing mammographically occult cancers and can provide…
Expand
2011
2011
P2-13-07: Prevalence of Germline BRCA1 and BRCA2 Deleterious Mutations in Brazilian Patients with High-Risk of Breast and Ovarian Cancer.
M. Diz
,
K. Escobar
,
+5 authors
M. Federico
2011
Corpus ID: 72579158
Background: Germline mutations in the BRCA1/2 genes account for the majority of hereditary breast ovarian cancer (HBOC…
Expand
Review
2011
Review
2011
P4-10-04: Automated Breast Cancer Risk Assessment: Identifying High Risk Women in the Primary Care Setting.
E. Ozanne
,
Z. Omer
,
K. Carlson
2011
Corpus ID: 76574613
Background: Despite the availability of risk assessment tools and risk-reducing interventions, high risk women are not routinely…
Expand
2010
2010
Evaluation of the potential clinical utility of risk models incorporating genomic risk information.
Elizabeth A. Comen
,
L. Balistreri
,
+4 authors
M. Robson
2010
Corpus ID: 78933292
1528 Background: For women at increased risk of breast cancer (BC), MRI is recommended at a >20% lifetime risk and tamoxifen at…
Expand
2009
2009
Assessing personal and family history characteristics of patients seeking cancer risk assessment due to direct-to-consumer marketing in a high risk clinic.
R. Legare
,
J. Kent
,
J. S. Wilbur
2009
Corpus ID: 75280532
Abstract #1100 BACKGROUND : The use of Direct-to-Consumer Marketing(DTC) for cancer genetic testing may result in more patients…
Expand
2007
2007
Genomic analysis detects two distinct molecular subtypes of ER-positive breast cancer
Nature Clinical Practice Oncology
2007
Corpus ID: 30734998
PancPRO is based on the framework developed for BRCAPRO, a well-documented risk predictor in breast cancer. The PancPRO model…
Expand
2007
2007
The radiation sensitizer AK-2123 prolongs survival in patients with stage III cervical cancer
Nature Clinical Practice Oncology
2007
Corpus ID: 37990112
PancPRO is based on the framework developed for BRCAPRO, a well-documented risk predictor in breast cancer. The PancPRO model…
Expand
2006
2006
Evaluation of the BRCAPRO model in a cohort of Hispanic families.
K. Vogel
,
Deann P D Atchley
,
+8 authors
B. Arun
2006
Corpus ID: 78732890
A32 Background: Approximately 7-10% of breast cancers and 10-15% of ovarian cancers are hereditary, the majority of which are…
Expand